Medicated Skincare in New Zealand

Euromonitor International, December 2005, Pages: 42

Our Medicated Skin Care in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (1999-2004), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2009 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
- Get a detailed picture of the medicated skin care industry
- Identify factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop

With a network of over 600 analysts worldwide, we have a unique capability to develop reliable information resources to help drive informed strategic planning.

Customers who bought this item also bought

• Medicated Skin Care in Cameroon
• Medicated Skin Care in New Zealand
• Medicated Skin Care in Guatemala
• Medicated Skin Care in Portugal
• Medicated Skin Care In Uruguay
• Medicated Skin Care in Algeria
• Medicated Skin Care in Sweden
• Medicated Skin Care in Tunisia
• Medicated Skin Care in Bosnia-Herzegovina
• Medicated Skin Care in Hungary